Stock Events

Stock Events

Ocugen 

$1.3300
806
-$0.04-3.27% 15:23 Today

Statistics

Day High
1.38
Day Low
1.32
52W High
2.73
52W Low
0.98
Volume
805,846
Avg. Volume
6,499,993
Mkt Cap
451.02M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

10NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.07
-0.06
-0.06
-0.05
Expected EPS
-0.06
Actual EPS
N/A

Financials

-1,537.41%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
4.41MRevenue
-67.85MNet Income

Analyst Ratings

9.50Average Price Target
The highest estimate is 11.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow OCGN. It's not an investment recommendation.
Apple
107
AAPL
Amazon
97
AMZN
Tesla
92
TSLA
NVIDIA
88
NVDA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap25.28B
Moderna is a competitor because it focuses on mRNA technology for vaccines, including COVID-19, similar to Ocugen's focus on developing a COVID-19 vaccine.
BioNTech
BNTX
Mkt Cap23.38B
BioNTech competes directly with Ocugen in the COVID-19 vaccine space, having developed one of the first mRNA vaccines for the virus.
Novavax
NVAX
Mkt Cap1.33B
Novavax is a competitor due to its work on developing protein-based vaccines for COVID-19, offering an alternative to Ocugen's vaccine approach.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is a major player in the COVID-19 vaccine market, competing with Ocugen through its collaboration with BioNTech to develop an mRNA vaccine.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson competes with Ocugen by offering a viral vector COVID-19 vaccine, providing a different technology approach in the same market.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is in competition with Ocugen due to its viral vector vaccine for COVID-19, which is a direct alternative to Ocugen's vaccine development efforts.
Inovio Pharmaceuticals
INO
Mkt Cap112.7M
Inovio Pharmaceuticals is a competitor because it is developing DNA-based vaccines for COVID-19, positioning it as an alternative to Ocugen's vaccine technology.
Arbutus Biopharma
ABUS
Mkt Cap923.95M
Arbutus Biopharma competes with Ocugen in the broader field of biopharmaceuticals, focusing on viral diseases and vaccine technologies.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline is a competitor because it is involved in the development and distribution of vaccines, including efforts towards COVID-19, competing in the same market as Ocugen.

About

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Show more...
CEO
Shankar Musunuri
Employees
116
Country
United States
ISIN
US67577C1053
WKN
000A2PSZH

Listings

F
DE
2H51.F
STU
DE
2H51.STU
MU
DE
2H51.MU
BOATS
BOATS
OCGN.BOATS

0 Comments

Share your thoughts

FAQ

What is Ocugen stock price today?▼
The current price of OCGN is $1.33 USD — it has decreased by -3.27% in the past 24 hours. Watch Ocugen stock price performance more closely on the chart.
What is Ocugen stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Ocugen stocks are traded under the ticker OCGN.
Is Ocugen stock price growing?▼
OCGN stock has fallen by -2.92% compared to the previous week, the month change is a -2.21% fall, over the last year Ocugen has showed a +27.88% increase.
What is Ocugen market cap?▼
Today Ocugen has the market capitalization of 451.02M
When is the next Ocugen earnings date?▼
Ocugen is going to release the next earnings report on November 10, 2026.
What were Ocugen earnings last quarter?▼
OCGN earnings for the last quarter are -0.07 USD per share, whereas the estimation was -0.05 USD resulting in a -31.25% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Ocugen revenue for the last year?▼
Ocugen revenue for the last year amounts to 4.41M USD.
What is Ocugen net income for the last year?▼
OCGN net income for the last year is -67.85M USD.
How many employees does Ocugen have?▼
As of August 18, 2026, the company has 116 employees.
In which sector is Ocugen located?▼
Ocugen operates in the Health & Wellness sector.
When did Ocugen complete a stock split?▼
The last stock split for Ocugen was on September 30, 2019 with a ratio of 1:60.
Where is Ocugen headquartered?▼
Ocugen is headquartered in MALVERN, United States.